Skip to content
Search for:
Home
About Us
Leadership
Board of Directors
Company History
Distributors
Careers
Legal
Non-Viral
Products
Instruments
ATxâ„¢
GTxâ„¢
STxâ„¢
VLxâ„¢
Consumables
RUO Processing Assemblies
Processing Assemblies Accessories
GMP Processing Assemblies
Processing Assemblies Order / Quote Request
Resources
Applications
Cell-Based Assays
Gene Editing
Primary Cells
Protein Production
Stem Cells
TCR/CAR T
Publications
Application Notes
Posters
Primary Literature
Product Literature
Webinars
White Papers
Scientific Brief
Scientific Presentation
Investors
Events
News
MaxCyte® Minutes
Twitter feed
Virtual 3D booth
News Releases
Events
Upcoming Events
Webinars Series
On Demand Live Seminars
Investor Events
Contact Us
Search for:
Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering
Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering
St Jones
2020-12-02T17:35:20+00:00
When it comes to protein expression, manufacturers have a choice among a range of technologies for implementation.
Download PDF
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter
Sign Up
Go to Top
